Post Tagged with: "FDA"

Amgen and Allergan submit biosimilar Biologics License Application for ABP 980 to US FDA

Celltrion and Teva announce U.S. FDA acceptance of BLA for proposed biosimilar to Herceptin (trastuzumab)

Merck announces launch of Renflexis (Remicade biosimilar) in the United States

Merck receives tentative approval for LUSDUNA Nexvue (insulin glargine injection) from FDA

FDA Oncologic Drugs Advisory Committee unanimously recommends approval of Mylan and Biocon’s proposed biosimilar trastuzumab
